Sickle Cell Disease And Hematopoietic Stem Cell Transplantation at Meripustak

Sickle Cell Disease And Hematopoietic Stem Cell Transplantation

Books from same Author: Emily R Meier and Allistair Abraham and Ross M Fasano

Books from same Publisher: SPRINGER

Related Category: Author List / Publisher List


  • Retail Price: ₹ 12700/- [ 11.00% off ]

    Seller Price: ₹ 11303

Sold By: MeriPustak      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 11.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 11.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Emily R Meier and Allistair Abraham and Ross M Fasano
    PublisherSPRINGER
    ISBN9783319623276
    Pages334
    BindingHardbound
    LanguageEnglish
    Publish YearOctober 2017

    Description

    SPRINGER Sickle Cell Disease And Hematopoietic Stem Cell Transplantation by Emily R Meier and Allistair Abraham and Ross M Fasano

    This book provides a comprehensive, state-of-the art review of hematopoietic stem cell transplantation (HSCT) for sickle cell disease (SCD). The book reviews new data about risk prediction for severe SCD, outlines the unique challenges of HSCT for patients with SCD, profiles the supportive care guidelines for patients who are undergoing HSCT, highlights our current understanding of the best transfusion support for SCD patients prior to, during and after HSCT, and provides new perspectives about the ethics of HSCT for pediatric patients with SCD. Published in the last few years, several landmark phase III trials that utilize matched unrelated and haploidentical donors for HSCT in SCD patients are also placed in context with respect to current management. Written by experts in the field, Sickle Cell Disease and Hematopoietic Stem Cell Transplantation is a valuable resource for physicians and researchers dealing with and interested in this challenging, yet exciting, curative therapy for sickle cell disease, that will help guide patient management and stimulate investigative efforts.